Date | Â | Immune-related analysis | |
---|---|---|---|
December 2010 (Dec-2010) | biopsy | IHC: MART-1/Melan-A +; S-100 +; gp100/HMB-45 + | Â |
November 2011 | surgery | IHC: MART-1/Melan-A +; S-100 +; gp100/HMB-45 + | Â |
January 2012 (Jan-2012) | sunitinib | Â | Immunological monitoring: |
April 2012 | surgery | IHC: MART-1/Melan-A -; S-100 +; gp100/HMB-45 +; CD3 +; CD8 + | • Frequency of immunosuppressive cells and CD3+ T cell function (Figure 4) |
May 2012/April 2013 | sunitinib* |  | • Presence of Melan-A/MART-1 specific CD8+ T cells (Figure 3) |